Sort
10,766 grants matching “checkpoint inhibitor”
Developing novel combination therapies for pancreatic cancer
$339,694Karina J Yoon · University Of Alabama At Birmingham · R01 · FY2020 · CA
Project 1: Targeting Metabolic Vulnerabilities in Lung Cancer
$339,660Ralph J Deberardinis · Ut Southwestern Medical Center · P50 · FY2021 · CA
Targeting Radiation-Induced Glioblastoma Invasion
$339,436Satoru Osuka · University Of Alabama At Birmingham · R01 · FY2025 · NS
Project 3: Maximizing Anti-tumor Activity through Simultaneous Activation of the Innate and Adaptive Immune System in Kidney Cancer
$339,344Raquibul Hannan · Ut Southwestern Medical Center · P50 · FY2023 · CA
Project 1: New epigenetic therapy targets
$339,301Jean-Pierre J Issa · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA
Rational Sequencing of PD-1 and CTLA-4 Antibodies in Metastatic Melanoma
$339,297Jeffrey S Weber · New York University School Of Medicine · R01 · FY2016 · CA
Rational Sequencing of PD-1 and CTLA-4 Antibodies in Metastatic Melanoma
$339,297Jeffrey S Weber · New York University School Of Medicine · R01 · FY2017 · CA
Dissecting and targeting oncogenic functions of PAK4 in high-risk rhabdomyosarcoma
$339,158Jason Yustein · Emory University · R01 · FY2024 · CA
Aging and DNA damage: Mechanisms for extending health span
$339,038Jan Hoeijmakers · Albert Einstein College Of Medicine, Inc · P01 · FY2018 · AG
Strategies to Disrupt Oncogenic Transcription in RCC Tumors
$339,008Chunling Yi · Georgetown University · R01 · FY2024 · CA
Project 3: Targeting Bax signaling to overcome treatment resistance in NSCLC
$338,910Xingming Deng · Emory University · P50 · FY2021 · CA
Immune Checkpoint Inhibition and humoral immune response in systemic autoimmunity
$338,898Hu Zeng · Mayo Clinic Rochester · R01 · FY2024 · AR
Combining senescence-inducing and senolytic agents to improve melanoma therapy
$338,882Anna E Vilgelm · Ohio State University · R37 · FY2025 · CA
Project 2: Neo-antigen Vaccines for Pancreatic and Colorectal Cancers
$338,877Elizabeth Marion Jaffee · Johns Hopkins University · P50 · FY2019 · CA
Project 2: Neo-antigen Vaccines for Pancreatic and Colorectal Cancers
$338,877Elizabeth Marion Jaffee · Johns Hopkins University · P50 · FY2022 · CA
Mechanisms of liver metastasis and associated resistance to immunotherapy
$338,826Benjamin Izar · Columbia University Health Sciences · R37 · FY2025 · CA
Project 2: Targeting RTK Co-Dependencies in Triple-Negative Breast Cancer
$338,693Thomas Westbrook · Baylor College Of Medicine · P50 · FY2020 · CA
Translesion Synthesis DNA Polymerases and Genome Instability
$338,625Polina V Shcherbakova · University Of Nebraska Medical Center · R01 · FY2015 · ES
Translesion Synthesis DNA Polymerases and Genome Instability
$338,625Polina V Shcherbakova · University Of Nebraska Medical Center · R01 · FY2018 · ES
Translesion Synthesis DNA Polymerases and Genome Instability
$338,625Polina V Shcherbakova · University Of Nebraska Medical Center · R01 · FY2016 · ES
Translesion Synthesis DNA Polymerases and Genome Instability
$338,625Polina V Shcherbakova · University Of Nebraska Medical Center · R01 · FY2017 · ES
Translesion Synthesis DNA Polymerases and Genome Instability
$338,625Polina V Shcherbakova · University Of Nebraska Medical Center · R01 · FY2014 · ES
Tumor-Associated Antigen Delivery using Protein Nanoparticles for Combined Immunotherapy
$338,612Szu-Wen Wang · University Of California-Irvine · R01 · FY2019 · EB
Inhibition of the ALT pathway by interfering with Poly-ADP-Ribose metabolism
$338,612Roderick O'Sullivan · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · CA
Project 2: Measuring and modeling the tumor and immune microenvironment before and during therapy and at the time of drug resistance
$338,537Arlene H Sharpe · Harvard Medical School · U54 · FY2020 · CA